Despite significant progress in medicinal chemistry and life sciences research, drug discovery and development remain slow and expensive, taking on average approximately 15 years and US$2 billion to ...

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein transthyretin that cause ...

Learn how AI drug discovery is revolutionising pharmaceutical research through collaboration with Eli Lilly and Schrödinger.

Schrödinger (SDGR) stock and Revvity (RVTY stock are in focus as firms join Eli Lilly (LLY) to integrate their software with ...

An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...

A team of chemists has unveiled a novel method to simplify the synthesis of piperidines, a key structural component in many pharmaceuticals. The study combines biocatalytic carbon-hydrogen oxidation ...

Disease modeling and target identification are critical and time-consuming portions of the drug discovery process and areas where artificial intelligence (AI) is already making a substantial impact. A ...

A recent study shows that computer algorithms can be used to find molecules that can be developed into anti-inflammatory drugs. In the article, the researchers also describe how the same strategy can ...

Schrödinger (SDGR) on Friday announced a collaboration with Eli Lilly (LLY) to integrate its drug development software ...

ISM5939 is being advanced as a therapy for cancer immunotherapy and the treatment of Hypophosphatasia. ISM5939 is a potentially best-in-class oral ENPP1 inhibitor with a novel molecular structure.

Vijayapura: The Centre of Advanced Medical Research (CAMR), in collaboration with the school of applied science and technology at BLDE (Deemed to be U.